Innovage Holding Corp

InnovAge Holding Corp. engages in the provision of a healthcare delivery platform. It offers interdisciplinary care teams and community-based care delivery models. It operates through the PACE and All Other segments. The PACE segment consists of the West, Central, and East operations. The All Other segment consists of homecare and senior housing. The company was founded in 2007 and is headquartered in Denver, CO.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

INNV reports improved financial performance and focuses on growth opportunities

INNV's Q1 2023 earnings call highlighted improved financial performance, successful resolution of audit deficiencies, and a focus on growth in new markets. The company faces challenges related to Medicaid redetermination and enrollment ramp-up, but expresses confidence in its direction and excitement for the future.

Innovage Holding Corp addresses revenue decline, EBITDA loss challenges post-sanctions

Innovage Holding Corp navigates revenue decline and EBITDA loss challenges post-sanctions, focusing on responsible growth and operational efficiency. The company aims to influence Medicaid rates, drive cost savings, and expand capacity strategically.

Innovage Holding Corp reports improved Q3 performance and eyes Florida expansion

Innovage Holding Corp's Q3 performance reflects operational improvements, cost reductions, and strategic advancements in market expansion.
The company's strengths lie in resolving audit deficiencies, entering the Florida market, and maintaining a positive outlook for future growth.
Challenges include enrollment ramp-up, regulatory compliance timelines, and applying lessons learned effectively across different centers.
Opportunities for growth include expanding as a PACE provider, diversifying services, and optimizing cost-saving initiatives for sustained profitability.

InnovAge reports mixed FY 2023 results, eyes growth opportunities

InnovAge's FY 2023 performance showed resilience and improvement in Q4 results.
The company's strengths lie in enrollment growth, cost reduction initiatives, and COVID management.
Challenges include Medicaid redeterminations, resource constraints, and COVID impact monitoring.
Opportunities for growth include new center openings, cost savings, and stable enrollments.

Innovage Holding Corp reports solid Q1 performance amidst growth challenges

Innovage Holding Corp reported solid Q1 2024 performance with revenue of $182.5 million and a focus on growth strategies. The company faced challenges with a net loss of $11 million and external provider costs.
Strengths included strong revenue performance, employee engagement initiatives, and proactive cost management strategies. Opportunities exist in optimizing costs, enhancing enrollment trends, and exploring new growth markets.
Key takeaways revolve around financial performance, operational strengths, challenges in cost management, and growth opportunities. Innovage's focus on quality improvement and agile hiring practices sets a positive trajectory for future performance.

InnovAge Holding Corp (INNV) reports strong Q2 earnings and strategic expansion, poised for sustainable growth

InnovAge Holding Corp (INNV) delivered strong financial performance in Q2 2024, with revenue growth, improved EBITDA, and strategic acquisitions. The company's focus on compliance, expansion efforts, and commitment to transparency are key highlights.
While facing challenges such as seasonality impact and achieving margin progression targets, InnovAge has opportunities to optimize EBITDA, capitalize on market demand, and drive operational efficiency. Addressing administrative delays and regulatory changes will be crucial for sustained growth.
Investors can look forward to InnovAge's Investor Day for deeper insights into the company's transformation and leadership team, signaling a proactive approach to enhancing shareholder value and operational excellence.

InnovAge reports revenue growth and margin focus amidst operational challenges

InnovAge Holding Corp (INNV) showed resilience with revenue growth and a focus on margin improvement despite challenges.
The company's performance metrics reflect efforts to enhance operational efficiency and financial stability.
Addressing challenges and seizing opportunities will be key for InnovAge's sustained success and growth in the healthcare industry.

Innovage Holding Corp reports solid fiscal 2024 performance and guides cautiously for 2025

Innovage Holding Corp's fiscal 2024 performance was solid, with revenue and adjusted EBITDA meeting expectations.
The company faces challenges in enrollment processing and de novo center operations but is actively working on solutions.
Fiscal year 2025 guidance reflects a balanced approach to growth, margin improvement, and regulatory compliance.
Analyst questions addressed key concerns, indicating a focus on transparency and addressing investor inquiries.

InnovAge reports robust Q1 results, eyes growth amid operational challenges

InnovAge's Q1 2025 performance reflects strong revenue growth and operational improvements, driven by enrollment gains and cost management initiatives.
The company's focus on workforce satisfaction, service quality, and financial discipline positions it well for future success.
Challenges in achieving profitability for new centers and managing costs underscore areas for ongoing improvement and strategic focus.
Opportunities exist in optimizing operational efficiency, exploring new markets, and enhancing revenue streams for sustained growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

InnovAge Holding Corp. engages in managing the care of high-cost, frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). The company program is dedicated to enabling older adults to age independently in their own homes for as long as safely possible. It offers interdisciplinary care teams and community-based care delivery models. The company was founded in 2007 and is headquartered in Denver, CO.

DENVER, Jan. 23, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare provider and payer for high-cost, dual-eligible seniors, announced today the release of enrollment sanctions for its six Colorado centers by the Centers for Medicare & Medicaid Services (CMS) and the Colorado Department of Healthcare Policy and Finance (HCPF).

State and Federal Regulators Lift Sanctions at InnovAge's Colorado PACE Centers

The US healthcare industry faces issues of rising costs and fragmentation. InnovAge platform addresses the needs of dual-eligible seniors.

InnovAge Holding: Wait For Audit Overhang To Pass Before Investing

DENVER, Jan. 05, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced that President and CEO Patrick Blair will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 11, 2023, at 3:45 p.m. (PT) / 6:45 p.m. (ET). The presentation will be webcast live, and the webcast link and related presentation materials for the event will be available online on the investor relations section of the Company's website.

InnovAge Announces Participation at the 41st Annual J.P. Morgan Healthcare Conference

DENVER, Nov. 22, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced today that the Centers for Medicare & Medicaid Services (CMS) has determined that effective immediately the sanction is released from InnovAge in Sacramento, California and it will return to normal enrollment status for Medicare-eligible participants. The California Department of Health Care Services (DHCS) continues to conduct its validation audit and has not lifted the state sanction. The DHCS audit outcome determines InnovAge's ability to enroll Medicaid recipients, which is required to enroll seniors with both Medicare and Medicaid.

InnovAge Announces Release of CMS Sanction in Sacramento Center

InnovAge Holding Corp. (NASDAQ:INNV ) Q1 2023 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Ryan Kubota - Director of IR Patrick Blair - President and CEO Barbara Gutierrez - CFO Rich Feifer - Chief Medical Officer Conference Call Participants Calvin Sternick - JPMorgan Madeline Mollman - William Blair Jason Cassorla - Citi Operator Good day, ladies and gentlemen, and thank you for standing by. Welcome to the InnovAge First Quarter 2023 Earnings Conference Call.

InnovAge Holding Corp. (INNV) Q1 2023 Earnings Call Transcript

InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -150% and 1.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

InnovAge Holding Corp. (INNV) Reports Q1 Loss, Lags Revenue Estimates

DENVER, Nov. 08, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced financial results for its fiscal first quarter ended September 30, 2022.

InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2022

InnovAge Holding Corp. (INNV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: InnovAge Holding Corp. (INNV) Q1 Earnings Expected to Decline

DENVER, Oct. 25, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV) will release its 2023 fiscal first quarter financial results on Tuesday, November 8, 2022, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T.

InnovAge to Announce Fiscal First Quarter 2023 Financial Results and Host Conference Call Tuesday, November 8, 2022

HCI Group

Spirit AeroSystems Hlds

Tandem Diabetes Care

Stocks like INVV, SPR, TNDM and HCI could prove hazardous for your portfolio. So, it's best to dump these toxic stocks, especially amid the prevailing market mayhem.

4 Toxic Stocks That May Risk Your Peace and Prosperity

InnovAge Holding Corp. (NASDAQ:INNV ) Q4 2022 Results Conference Call September 13, 2022 5:00 PM ET Company Participants Ryan Kubota - IR Patrick Blair - President and CEO Barbara Gutierrez - CFO Rich Feifer - Chief Medical Officer Conference Call Participants Jason Cassorla - Citigroup Sarah James - Barclays Jamie Perse - Goldman Sachs Madeline Mollman - William Blair Operator Good day and thank you for standing by. Welcome to the InnovAge Fourth Quarter 2022 Earnings Conference Call.

InnovAge Holding Corp. (INNV) Q4 2022 Earnings Call Transcript

InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -200% and 0.74%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

InnovAge Holding Corp. (INNV) Reports Q4 Loss, Lags Revenue Estimates

DENVER, Sept. 13, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced financial results for its fiscal fourth quarter and full year ended June 30, 2022.

InnovAge Announces Financial Results for the Fiscal Year and Fourth Quarter Ended June 30, 2022

Adobe

Core & Main

IronNet

Matrix Service

Oracle

Planet Labs

Rent the Runway

Vintage Wine Estates

Given the Fed tightening and the resulting macro uncertainties, many were expecting below par performances, but the second quarter turned out to be better than expected in terms of earnings.

These Are The 10 Biggest Firms Releasing Earnings Next Week

Wilmington, Delaware--(Newsfile Corp. - September 6, 2022) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of InnovAge Holding Corp. (NASDAQ: INNV) on behalf of stockholders.To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-innovage-holding-corp.To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.Rigrodsky Law, P.A.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating InnovAge Holding Corp.

DENVER, Sept. 02, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV) will release its 2022 fiscal fourth quarter financial results on Tuesday, September 13, 2022, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T.

InnovAge to Announce Fiscal Fourth Quarter 2022 Financial Results and Host Conference Call Tuesday, September 13, 2022

DENVER, Aug. 29, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), has named Kathy Andreasen as its Chief People Officer (CPO) effective Aug. 29, 2022.

InnovAge Names Kathy Andreasen its Chief People Officer

DENVER, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Today, InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), named Richard Feifer, MD, MPH, as its chief medical officer (CMO) effective Aug. 15, 2022.

InnovAge Names Richard Feifer, MD, MPH, as Chief Medical Officer

DENVER, June 30, 2022 (GLOBE NEWSWIRE) -- InnovAge (NASDAQ: INNV), today announced the appointment of experienced health care executive James (“Jim”) Carlson to its Board of Directors, effective June 30, 2022. Carlson will serve as non-executive Chairman.

InnovAge Appoints James Carlson to the Board as Non-Executive Chairman

Philadelphia, Pennsylvania--(Newsfile Corp. - May 28, 2022) - Kaskela Law LLC announces that it is investigating InnovAge Holding Corp. (NASDAQ: INNV) ("InnovAge" or the "Company") on behalf of the Company's long-term stockholders.In March 2021, InnovAge completed its initial public offering ("IPO") of common stock, selling 19 million shares of stock to investors at a price of $21.00 per share.On September 21, 2021, InnovAge revealed that the Centers for Medicare and Medicaid Services ("CMS") had "determined...

INNV SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of InnovAge Holding Corp. and Encourages Current INNV Stockholders to Contact the Firm

LogicMark

LOUISVILLE, Ky. , May 24, 2022 /PRNewswire/ -- LogicMark, Inc. (Nasdaq: LGMK) (the "Company" or "LogicMark") (formerly Nxt-ID, Inc.), a provider of personal emergency response systems (PERS), health communications devices, and IoT technology for the growing care economy, today announces the appointment of seasoned financial executive Barbara Gutierrez to its Board of Directors.

LogicMark, Inc. Appoints Barbara Gutierrez to Board of Directors

Ligand Pharmaceuticals

Madison Square Garden Entertainment

Materialise NV

Getting rid of fundamentally weak toxic stocks is important to shield your portfolio from losses. MSGE, MTLS, INNV and LGND are a few toxic stocks according to our model that you should dump now.

Detoxify Your Holdings by Steering Clear of These 4 Stocks

InnovAge Holding Corp. (NASDAQ:INNV ) Q3 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Ryan Kubota - Director, Investor Relations Patrick Blair - President and Chief Executive Officer Barbara Gutierrez - Chief Financial Officer Melissa Welch - Chief Medical Officer Conference Call Participants Jeff Garro - Piper Sandler Sarah James - Barclays Jamie Perse - Goldman Sachs Matt Larew - William Blair Andrew Lothian - JPMorgan Operator Good day and thank you for standing by and welcome to the InnovAge Fiscal Third Quarter 2022 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your host today, Ryan Kubota, Director of Investor Relations.

InnovAge Holding Corp. (INNV) CEO Patrick Blair on Q3 2022 Results - Earnings Call Transcript

PHILADELPHIA , May 11, 2022 /PRNewswire/ -- Investor protection law firm Kaskela Law LLC announces that it is investigating InnovAge Holding Corp. (NASDAQ: INNV) ("InnovAge" or the "Company") on behalf of the Company's long-term stockholders.  Current InnovAge stockholders who purchased or acquired shares of the Company's stock prior to September 21, 2021  are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of InnovAge Holding Corp. and Encourages Long-Term Investors to Contact the Firm - INNV

InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -300% and 5.40%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

News for Innovage Holding Corp Stock (INNV)